Additionally, studies have reported that AG490, a JAK2 inhibitor, suppresses angiogenesis and reduces MDSCs within the HNSCC TME by inhibiting the JAK2/STAT3 pathway [27, 278]. Here, JAK2 is linked to head and neck squamous cell carcinoma.